PUBLISHER: The Business Research Company | PRODUCT CODE: 1877541
PUBLISHER: The Business Research Company | PRODUCT CODE: 1877541
Barrier packaging materials for pharmaceuticals are specialized packaging solutions developed to protect pharmaceutical products from environmental factors such as moisture, oxygen, light, and microbial contamination. These materials help maintain the stability, efficacy, and shelf life of drugs by preventing degradation and ensuring consistent product quality during storage and transportation.
The main material types of barrier packaging materials for pharmaceuticals include aluminum foil barrier materials, polymer film barrier materials, multi-layer barrier systems, and advanced barrier technologies. Aluminum foil barrier materials consist of thin aluminum sheets used in pharmaceutical packaging to shield drugs from moisture, light, and oxygen, thereby preserving stability and extending shelf life. These materials are utilized in various packaging formats such as blister packaging, flexible packaging, rigid packaging, and specialized packaging designs. They are applied in solid dosage forms, liquid and semi-solid formulations, and biologics and biosimilars, with end users including branded drug manufacturers, generic drug companies, and contract development and manufacturing organizations (CDMOs).
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.
The barrier packaging materials for pharmaceuticals market research report is one of a series of new reports from The Business Research Company that provides barrier packaging materials for pharmaceuticals market statistics, including barrier packaging materials for the pharmaceuticals industry's global market size, regional shares, competitors with barrier packaging materials for pharmaceuticals market share, detailed barrier packaging materials for pharmaceuticals market segments, market trends and opportunities, and any further data you may need to thrive in the barrier packaging materials for the pharmaceuticals industry. This barrier packaging materials for the pharmaceuticals market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The barrier packaging materials for pharmaceuticals market size has grown strongly in recent years. It will grow from $30.15 billion in 2024 to $33.07 billion in 2025 at a compound annual growth rate (CAGR) of 9.7%. The growth during the historic period was driven by the increasing demand for safe drug storage, rising pharmaceutical production, growing awareness of product contamination, expansion of cold chain logistics, and heightened awareness of medication mishaps.
The barrier packaging materials for pharmaceuticals market size is expected to see strong growth in the next few years. It will grow to $47.29 billion in 2029 at a compound annual growth rate (CAGR) of 9.4%. The growth during the forecast period will result from increasing investment in biopharmaceuticals, the rise of e-commerce in the pharmaceutical sector, the expansion of personalized medicine, growing focus on sustainability, and increasing demand for high-barrier packaging solutions. Major trends in the forecast period include technological advancements in multilayer films, progress in biodegradable barrier materials, innovation in smart and active packaging, development of new barrier types, and integration of eco-friendly materials in barrier packaging.
The growth of biologic drugs is expected to drive the expansion of the barrier packaging materials for the pharmaceuticals market in the coming years. Biologic drugs are therapeutic products derived from living cells or organisms that are used to treat diseases not effectively managed by traditional chemical drugs. The rising demand for biologic drugs is attributed to the increasing prevalence of chronic and complex diseases that require targeted and effective treatment options. Barrier packaging materials for pharmaceuticals enhance drug safety and stability by protecting biologic drugs from moisture, oxygen, light, and microbial contamination. These materials help prevent degradation, extend shelf life, and maintain product efficacy, ensuring patient safety. For example, in May 2022, according to the European Pharmaceutical Review (EPR), a UK-based non-governmental organization, biologics are projected to significantly surpass sales of innovative small molecules within the next five years, with an estimated $120 billion increase in sales by 2027. Therefore, the expansion of biologic drugs is fueling the growth of the barrier packaging materials for the pharmaceuticals market.
Major companies operating in the barrier packaging materials for pharmaceuticals market are focusing on developing advanced solutions such as innovative pharmaceutical packaging to enhance drug stability, extend shelf life, and ensure patient safety. Innovative pharmaceutical packaging solutions involve modern approaches that improve drug protection, maintain product integrity, and optimize storage and transportation, often featuring barrier materials, tamper-evident components, or digital tracking technologies. For example, in February 2025, LOG Pharma Primary Packaging, an Israel-based manufacturing company, introduced a new barrier eco line at Pharmapack Europe to provide sustainable, high-performance packaging solutions that safeguard pharmaceuticals. This solution reduces bottle weight by up to 30% while maintaining excellent moisture and oxygen barrier protection to ensure drug stability. It incorporates advanced pharma-grade HEALTH+ resins from Dow, offering sustainable, cost-effective packaging that minimizes environmental impact without compromising performance. This innovation helps pharmaceutical companies achieve sustainability objectives and lower packaging costs while maintaining drug efficacy.
In February 2025, Perlen Packaging AG, a Switzerland-based manufacturing company, acquired Log Pharma Industries for an undisclosed amount. Through this acquisition, Perlen Packaging AG aims to strengthen its global presence and expand its capabilities in pharmaceutical packaging by integrating Log Pharma's complementary products and increasing its manufacturing reach in key growth markets. Log Pharma Industries is an Israel-based pharmaceutical company that provides barrier packaging materials for pharmaceuticals.
Major players in the barrier packaging materials for pharmaceuticals market are BASF SE, Honeywell International Inc., 3M Company, Amcor plc, DuPont de Nemours Inc., Toppan Printing Co. Ltd., Dai Nippon Printing Co. Ltd., Mondi Group, Sealed Air Corporation, AptarGroup Inc., West Pharmaceutical Services Inc., Gerresheimer AG, ProAmpac Holdings LLC, UFlex Limited, SCHOTT AG, Toray Plastics (America) Inc., Cosmo Films Limited, Sonoco Products Company, Glenroy Inc., Cadillac Products Packaging Company, Origin Pharma Packaging Ltd., Neelam Global Pvt. Ltd., and Vishakha Polyfab Private Limited.
North America was the largest region in the barrier packaging materials for pharmaceuticals market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in barrier packaging materials for the pharmaceuticals report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the barrier packaging materials for the pharmaceuticals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The barrier packaging materials for the pharmaceuticals market consists of sales of blister packs, high-barrier plastic bottles, pouches, vials, ampoules, and sachets. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Barrier Packaging Materials For Pharmaceuticals Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on barrier packaging materials for pharmaceuticals market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for barrier packaging materials for pharmaceuticals ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The barrier packaging materials for pharmaceuticals market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.